Page last updated: 2024-08-24

tangeretin and Prostatic Neoplasms

tangeretin has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chao, YH; Su, ZY; Tung, YC; Wei, GJ; Wu, TY	1

Other Studies

1 other study(ies) available for tangeretin and Prostatic Neoplasms

Article	Year
A Tangeretin Derivative Inhibits the Growth of Human Prostate Cancer LNCaP Cells by Epigenetically Restoring p21 Gene Expression and Inhibiting Cancer Stem-like Cell Proliferation. The AAPS journal, 2019, 07-10, Volume: 21, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Epigenesis, Genetic; Flavones; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplastic Stem Cells; Prostatic Neoplasms	2019

Article

Year

A Tangeretin Derivative Inhibits the Growth of Human Prostate Cancer LNCaP Cells by Epigenetically Restoring p21 Gene Expression and Inhibiting Cancer Stem-like Cell Proliferation.

The AAPS journal, 2019, 07-10, Volume: 21, Issue:5

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Epigenesis, Genetic; Flavones; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplastic Stem Cells; Prostatic Neoplasms

2019